Brian C Cornell, Director, Executive Officer, on May 27, 2026, sold 50,000 shares in Target (TGT) for $6,492,623. Following the Form 4 filing with the SEC, Cornell has control over a total of 327,272 common shares of the company, with 133,506 shares held directly and 193,766 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/27419/000128870926000010/xslF345X05/wk-form4_1780002107.xml
Erez Shachar, Director, on May 26, 2026, sold 65,569 shares in Riskified (RSKD) for $315,024. Following the Form 4 filing with the SEC, Shachar has control over a total of 5,173,099 Class A ordinary shares of the company, with 80,053 shares held directly and 5,093,046 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1851112/000160109926000007/xslF345X05/wk-form4_1780001887.xml
Jeffrey L Gendell, 10% Owner, Director, Executive Chairman, on May 26, 2026, sold 32,365 shares in Ies Holdings (IESC) for $22,839,955. Following the Form 4 filing with the SEC, Gendell has control over a total of 10,453,279 common shares of the company, with 10,453,279 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1048268/000104826826000108/xslF345X05/wk-form4_1780001910.xml
Terrance P. Coyne, Executive Vice President & CFO, on May 26, 2026, sold 64,399 shares in Royalty Pharma (RPRX) for $3,476,116. Following the Form 4 filing with the SEC, Coyne has control over a total of 50,390 Class A ordinary shares of the company, with 1,500 shares held directly and 48,890 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1802768/000181487626000022/xslF345X05/wk-form4_1780001297.xml